Arkolith/Insider Trading/KYTX

KYTX Insider Trading

KYTX · full profile →Last filing May 27, 2026
Mixed · 180d
Open-Market Buys (180d)
$0
0 insiders
Open-Market Sells (180d)
$0
0 insiders
Net Insider Flow
$0
open market, 180d
Reporting Insiders
0
0 P/S transactions
Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp

Recent Form 4 Transactions

91 shown
DateInsiderRoleActionSharesPriceValue
May 27, 2026Clark Ian TDirectorGrant(A)21K—$0
May 27, 2026Clark Ian TDirectorGrant(A)5K—$0
May 27, 2026Aktar MertDirectorGrant(A)21K—$0
May 27, 2026Aktar MertDirectorGrant(A)5K—$0
May 27, 2026Seidenberg Beth CDirectorGrant(A)21K—$0
May 27, 2026Seidenberg Beth CDirectorGrant(A)5K—$0
May 27, 2026Cohen Fred EDirectorGrant(A)21K—$0
May 27, 2026Cohen Fred EDirectorGrant(A)5K—$0
May 27, 2026Shaw ChristiExecutive Chairperson, DirectorTax withholding(F)4K$8.59$36K
May 18, 2026Martini Gregory S.Chief Financial OfficerGrant(A)325K—$0
May 4, 2026Dac NadiaChief Commercial OfficerGrant(A)300K—$0
Mar 13, 2026Biddle Warner WestonChief Executive Officer, DirectorGrant(A)58K—$0
Mar 13, 2026Biddle Warner WestonChief Executive Officer, DirectorGrant(A)350K—$0
Mar 13, 2026Grasso MarcChief Financial OfficerGrant(A)10K—$0
Mar 13, 2026Grasso MarcChief Financial OfficerGrant(A)65K—$0
Mar 13, 2026Gehchan NajiSee RemarksGrant(A)18K—$0
Mar 13, 2026Gehchan NajiSee RemarksGrant(A)105K—$0
Feb 24, 2026Emany Sravan KumarDirectorGrant(A)11K—$0
Feb 24, 2026Emany Sravan KumarDirectorGrant(A)43K—$0
Feb 24, 2026Miller Andrew CraigDirectorGrant(A)11K—$0
Feb 24, 2026Miller Andrew CraigDirectorGrant(A)43K—$0
Feb 9, 2026Pujols MayobanexChief Technology OfficerGrant(A)300K—$0
Jan 12, 2026Shaw ChristiExecutive Chairperson, DirectorGrant(A)30K—$0
Jan 12, 2026Shaw ChristiExecutive Chairperson, DirectorGrant(A)24K—$0
Jan 12, 2026Shaw ChristiExecutive Chairperson, DirectorGrant(A)185K—$0
Dec 18, 2025Westlake BioPartners Opportunity Fund I, L.P.10% OwnerBuy(P)133K$7.50$1000K
Dec 18, 2025Seidenberg Beth CDirectorBuy(P)133K$7.50$1000K
Dec 15, 2025Walker Karen MarieChief Technology OfficerOption exercise(M)24K$4.83$116K
Dec 15, 2025Walker Karen MarieChief Technology OfficerSell(S)24K$12.20$293K
Dec 15, 2025Walker Karen MarieChief Technology OfficerOption exercise(M)24K—$0
Jun 30, 2025Grasso MarcChief Financial OfficerGrant(A)450K—$0
May 29, 2025Cohen Fred EDirector, 10% OwnerGrant(A)17K—$0
May 29, 2025Cohen Fred EDirector, 10% OwnerGrant(A)65K—$0
May 29, 2025Clark Ian TDirectorGrant(A)17K—$0
May 29, 2025Clark Ian TDirectorGrant(A)65K—$0
May 29, 2025Aktar MertDirectorGrant(A)17K—$0
May 29, 2025Aktar MertDirectorGrant(A)65K—$0
May 29, 2025Spiegelman Daniel KDirectorGrant(A)17K—$0
May 29, 2025Spiegelman Daniel KDirectorGrant(A)65K—$0
May 29, 2025Seidenberg Beth CDirector, 10% OwnerGrant(A)17K—$0
May 29, 2025Seidenberg Beth CDirector, 10% OwnerGrant(A)65K—$0
May 29, 2025Shaw ChristiDirectorGrant(A)17K—$0
May 29, 2025Shaw ChristiDirectorGrant(A)65K—$0
Apr 11, 2025Walker Karen MarieChief Technology OfficerGrant(A)13K—$0
Apr 11, 2025Jones Ryan AlexanderChief Financial OfficerGrant(A)12K—$0
Feb 14, 2025Shaw ChristiDirectorGrant(A)39K—$0
Jan 22, 2025Gehchan NajiSee RemarksGrant(A)425K—$0
Oct 21, 2024Aktar MertDirectorGrant(A)88K—$0
Sep 16, 2024Shaw ChristiDirectorGrant(A)67K—$0
Sep 16, 2024Biddle Warner WestonChief Executive Officer, DirectorGrant(A)2.6M—$0
Jun 6, 2024Walker Karen MarieChief Technology OfficerOption exercise(M)10K$4.42$43K
Jun 6, 2024Walker Karen MarieChief Technology OfficerOption exercise(M)10K—$0
May 28, 2024Jones Ryan AlexanderChief Financial OfficerOption exercise(M)11K$0.73$8K
May 28, 2024Jones Ryan AlexanderChief Financial OfficerOption exercise(M)7K$0.73$5K
May 28, 2024Jones Ryan AlexanderChief Financial OfficerOption exercise(M)11K—$0
May 28, 2024Jones Ryan AlexanderChief Financial OfficerOption exercise(M)7K—$0
Apr 11, 2024Walker Karen MarieChief Technology OfficerGrant(A)80K—$0
Apr 11, 2024Jones Ryan AlexanderChief Financial OfficerGrant(A)74K—$0
Apr 11, 2024Biddle Warner WestonChief Executive Officer, DirectorGrant(A)333K—$0
Feb 12, 2024Northpond Ventures III GP, LLCInsiderBuy(P)450K$22.00$9.9M
Feb 12, 2024Northpond Ventures III GP, LLCInsiderConversion(C)2.8M——
Feb 12, 2024Northpond Ventures III GP, LLCInsiderConversion(C)12.8M——
Feb 12, 2024Bain Capital Life Sciences Fund III, L.P.10% OwnerConversion(C)2.7M——
Feb 12, 2024Bain Capital Life Sciences Fund III, L.P.10% OwnerBuy(P)450K$22.00$9.9M
Feb 12, 2024Bain Capital Life Sciences Fund III, L.P.10% OwnerConversion(C)12.4M—$0
Feb 12, 2024Seidenberg Beth CDirector, 10% OwnerConversion(C)3.8M——
Feb 12, 2024Seidenberg Beth CDirector, 10% OwnerConversion(C)736K——
Feb 12, 2024Seidenberg Beth CDirector, 10% OwnerConversion(C)4.0M—$0
Feb 12, 2024Seidenberg Beth CDirector, 10% OwnerConversion(C)8.8M—$0
Feb 12, 2024Seidenberg Beth CDirector, 10% OwnerConversion(C)4.4M—$0
Feb 12, 2024Seidenberg Beth CDirector, 10% OwnerConversion(C)3.3M—$0
Feb 12, 2024Cohen Fred EDirector, 10% OwnerConversion(C)4.5M——
Feb 12, 2024Cohen Fred EDirector, 10% OwnerConversion(C)8.8M—$0
Feb 12, 2024Cohen Fred EDirector, 10% OwnerConversion(C)4.4M—$0
Feb 12, 2024Cohen Fred EDirector, 10% OwnerConversion(C)7.4M—$0
Feb 12, 2024Vida Ventures GP III, L.L.C.10% OwnerConversion(C)4.5M——
Feb 12, 2024Vida Ventures GP III, L.L.C.10% OwnerBuy(P)253K$22.00$5.6M
Feb 12, 2024Vida Ventures GP III, L.L.C.10% OwnerBuy(P)583$22.00$13K
Feb 12, 2024Vida Ventures GP III, L.L.C.10% OwnerConversion(C)7.4M—$0
Feb 12, 2024Vida Ventures GP III, L.L.C.10% OwnerConversion(C)8.8M—$0
Feb 12, 2024Vida Ventures GP III, L.L.C.10% OwnerConversion(C)4.4M—$0
Feb 12, 2024Gilead Sciences, Inc.10% OwnerConversion(C)3.2M——
Feb 12, 2024Gilead Sciences, Inc.10% OwnerBuy(P)910K$22.00$20.0M
Feb 12, 2024Gilead Sciences, Inc.10% OwnerConversion(C)6.9M—$0
Feb 12, 2024Gilead Sciences, Inc.10% OwnerConversion(C)7.7M—$0
Feb 12, 2024Westlake BioPartners GP I, LLC10% OwnerConversion(C)3.8M——
Feb 12, 2024Westlake BioPartners GP I, LLC10% OwnerConversion(C)736K——
Feb 12, 2024Westlake BioPartners GP I, LLC10% OwnerConversion(C)8.8M—$0
Feb 12, 2024Westlake BioPartners GP I, LLC10% OwnerConversion(C)4.0M—$0
Feb 12, 2024Westlake BioPartners GP I, LLC10% OwnerConversion(C)3.3M—$0
Feb 12, 2024Westlake BioPartners GP I, LLC10% OwnerConversion(C)4.4M—$0

Data Source

Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.

Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.

Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).